Blood test predicts MS disability worsening up to two years in advance

Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new study spearheaded by researchers at UC San Francisco.

AstraZeneca CEO reaffirms commitment to China following executive’s detention

NEW YORK — AstraZeneca is not backing away from China despite an investigation into its president of China operations. As the company reported its third-quarter

November 13, 2024

Reinforcement learning improves performance of AI-based skin cancer diagnosis

Artificial intelligence (AI) is already being used to diagnose skin cancer, but it cannot (yet) keep pace with the complex decision-making of doctors in practice.

July 28, 2023

Health impacts and demographic inequities from nitrogen dioxide emissions in US homes using gas and propane stoves

Indoor nitrogen dioxide (NO2) emissions from gas and propane stoves and assessed their health impacts.

May 8, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.